Abbott GmbH recalls Alinity i Anti-HCV Reagent Kit, List Number 08P0521

Recall date

March 4, 2024

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Recall number

Z-1480-2024

FDA classification

Class II

Brand / firm

Abbott GmbH

Sold / distributed

US Nationwide distribution.

Why it was recalled

Customer complaints were received regarding falsely elevated results for some patient samples. Internal studies with customer return samples confirmed potential interactions that may lead to falsely elevated results when processed as below on the same instrument: " ARCHITECT Syphilis TP (LN 8D06) and/or ARCHITECT AdviseDx SARS-CoV-2-IgG II (LN 6S60) precedes ARCHITECT Anti-HCV testing (LN 1L79). " Alinity i Syphilis TP (LN 07P60) precedes Alinity i Anti-HCV testing (LN 08P05).

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Alinity i Anti-HCV Reagent Kit, List Number 08P0521